Earnings

Danaher returns a key business to growth, and we’re raising our stock rating back to buy

Danaher returns a key business to growth, and we’re raising our stock rating back to buy

In this photo illustration, a Danaher Corporation logo seen displayed on a tablet. 
Igor Golovnov | SOPA Images | Lightrocket | Getty Images

Danaher shares declined Tuesday despite the life sciences company returning its key bioprocessing business to growth in the third quarter.

View Article Origin Here

Related Articles

Back to top button